Differential diagnostic assay for brucellosis
Abstract
An immunoassay procedure is provided which exhibits increased specificity over current procedures. The procedure allows the differentiation of animals infected with Brucella abortus from animals vaccinated with Brucella abortus Strain 19. The invention employs unique monospecific monoclonal antibodies having particular affinity, specificity and binding characteristics directed to a B. abortus lipopolysaccharide antigen. The invention also concerns continuous hybrid cell lines for producing the unique monoclonal antibodies.
Subject
435/7.32435/7.5
435/7.9
435/7.93
435/329
435/340
435/975
436/518
530/388.4
530/810
530/825
G01N 33/56911
C07K 16/1221
Y10S 530/81
Y10S 435/975
G01N 2333/23
Y10S 530/825
G01N 2400/50
Collections
Citation
Adams, Leslie G.; Smith, Roger III; Templeton, Joe W.; Overholt, Kathleen A. (1993). Differential diagnostic assay for brucellosis. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /177530.